Condition: VAP - Ventilator Associated Pneumonia · Sponsor: BioMérieux
objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils
This description comes directly from the study's public registry record.
Jean-François LLITJOS · +33761568397 · jeanfrancois.llitjos@biomerieux.com
Marie-Angelique CAZALIS · +33626807839 · marie-angelique.cazalis@biomerieux.com
Always discuss trial participation with your own doctor first.
| Hopital Edouard Herriot | Lyon, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06073834